Sweden's Episurf Q4 revenue rises, expands into real estate

Episurf Medical AB

06/02/2026 07:38

Overview

Sweden's medical device maker's Q4 revenue rises yr/yr, reducing operating costs

Company forms new strategic segment with real estate acquisition

U.S. customer base grows 120% in 2025

Outlook

Episurf adds real estate segment to support medical device financing

Company focuses on expanding U.S. customer base

Episurf aims to update shareholders on real estate acquisition benefits

Result Drivers

U.S. MARKET GROWTH - Episurf saw a 120% increase in its U.S. customer base and a record number of procedures in Q4 2025

REAL ESTATE ACQUISITION - Company formed a new strategic segment by acquiring real estate assets to support medical device business

COST REDUCTION - Co reduced operating costs significantly in Q4 2025 compared to the same quarter in 2024

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
SEK 3.50 mln
Q4 EPS
-SEK 0.01
Q4 Net Income
-SEK 13.50 mln
Q4 Orders
SEK 3.50 mln


Analyst Coverage

Wall Street's median 12-month price target for Episurf Medical AB is SEK0.07, about 28.5% above its February 5 closing price of SEK0.05

Press Release: ID:nWkr8s6WdD

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)